Skip to main content
Equibles

Ambaw Bellete

COO

CG Oncology, Inc. (CGON)

Equibles does not estimate personal net worth.

Get an email with a short summary when CG Oncology, Inc. publishes a filing, an earnings call transcript or a press release.

Get CGON alerts

About Ambaw Bellete

Ambaw Bellete is recorded as COO at CG Oncology, Inc. (CGON). The newest filing on record that lists Ambaw Bellete as COO at CG Oncology, Inc. (CGON) is dated April 24, 2026. The proxy statement of CG Oncology, Inc. reports total compensation of $4,815,391 for Ambaw Bellete in fiscal 2025, including a base salary of $537,941. Disclosed compensation is on record for 3 fiscal years. Ambaw Bellete has spoken on 2 investor events across 1 company, most recently for CG Oncology, Inc. on May 20, 2026. CG Oncology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CG Oncology, Inc. includes Arthur Kuan (CEO), Corleen M. Roche (CFO), Jim DeTore (CFO) and 4 others.

Ambaw Bellete on recent calls

“I think when we looked at cohort CX and the design of the trial, we had a number of aims in that trial.”
CEO, RBC Capital Markets Global Healthcare Conference ·
“I think the way we see it is we've really tracked all the launches within this space, not just the Alexa launch. And we've really seen where they've hit the mark in terms of physicians and patients, where perhaps there's still some questions outstanding.”
COO, Bank of America Health Care Conference 2026 ·

Affiliation history

Company network

Leadership on record at CG Oncology, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 CG Oncology, Inc. (CGON) $537,941 $4,815,391
2024 CG Oncology, Inc. (CGON) $511,935 $5,241,391
2023 CG Oncology, Inc. (CGON) $322,000 $3,029,535

Recent activity